During the past decade, King Chulalongkorn Memorial Hospital; Division of Hematology, Department of Medicine conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "King Chulalongkorn Memorial Hospital; Division of Hematology, Department of Medicine" #1 collaborator was "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "King Chulalongkorn Memorial Hospital; Division of Hematology, Department of Medicine" are "B-cell Lymphoma" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "Lymphoma, Large B-Cell, Diffuse" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "King Chulalongkorn Memorial Hospital; Division of Hematology, Department of Medicine" in a lesser frequency.

Most popular intervention types in "King Chulalongkorn Memorial Hospital; Division of Hematology, Department of Medicine" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "CHOP" (2 trials), "Cyclophosphamide" (2 trials), "Obinutuzumab" (2 trials), "Rituximab" (2 trials) and "Bendamustine" (1 trials). Other intervention names were less common.

The vast majority of trials in "King Chulalongkorn Memorial Hospital; Division of Hematology, Department of Medicine" are 5 trials for "All" genders.

Currently, there are NaN active trials in "King Chulalongkorn Memorial Hospital; Division of Hematology, Department of Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in King Chulalongkorn Memorial Hospital; Division of Hematology, Department of Medicine, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in King Chulalongkorn Memorial Hospital; Division of Hematology, Department of Medicine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".